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Objectives. To assess the effects of interaction of sex hormones,
hypercholesterolemia (HC) and environmental tobacco smoke (ETS)
exposure on endothelium-dependent relaxation, we examined vascu-
lar reactivity in vitro in an animal model of atherogenesis.
Background. Animal and human studies indicate the presence
of interactions between classic coronary artery disease risk factors
and endothelium-dependent relaxation. Sex hormones have also
been shown to influence release of endothelium-derived relaxing
factor.
Methods. New Zealand White rabbits were randomized to
receive either an HC diet (n 5 8) or ETS exposure plus HC diet
(n5 8). Eight rabbits receiving a normal diet, without exposure to
ETS, served as the control group. The HC diet consisted of 3%
soybean oil and 0.3% cholesterol by weight over 13 weeks. The
source of ETS was sidestream smoke of 4 cigarettes/15 min,
6 h/day, 5 days/week over 10 weeks in a smoking chamber. Rabbits
were killed, and fresh aortic rings were harvested and maintained
in oxygenated Krebs solution in an organ bath at 37&C. Rings were
precontracted with norepinephrine and exposed to acetylcholine
in increasing doses, and isometric tension was recorded. Rings
were also exposed to physiologic concentrations (1 nmol/liter) of
either 17-beta-estradiol, testosterone or progesterone before pre-
contraction with norepinephrine and relaxation with acetylcho-
line. Endothelium-independent relaxation was studied using ni-
troglycerin. The surface area of the ring covered by lipids was
measured by Sudan IV staining.
Results. HC and ETS significantly reduced endothelium-
dependent relaxation (p 5 0.01 and p < 0.0005, respectively) and
caused atherogenesis (p < 0.0005 and p 5 0.047, respectively) but
did not affect endothelium-independent relaxation. Incubation
with estradiol and estradiol plus progesterone did not influ-
ence endothelium-dependent relaxation. Testosterone reduced
endothelium-dependent relaxation (p5 0.049) and augmented the
endothelial dysfunction associated with ETS exposure and HC
(p 5 0.03).
Conclusions. Both HC and ETS are atherogenic and impair
endothelial function but do not affect endothelium-independent
relaxation. Physiologic levels of estradiol and estradiol plus proges-
terone do not affect endothelium-dependent relaxation. Physiologic
levels of testosterone impair relaxation and augment the endothelial
dysfunction associated with ETS exposure and HC.
(J Am Coll Cardiol 1997;29:800–7)
q1997 by the American College of Cardiology
Impaired endothelial function is thought to be an early event in
the development of atherosclerosis. Endothelium-derived re-
laxing factor (EDRF)–mediated vasorelaxation is impaired by
hypercholesterolemia (HC) in both experimental animal mod-
els (1,2) and in humans (3–5) and by tobacco smoking (3,6–8).
More recently, passive exposure to environmental tobacco
smoke (ETS) has been shown in animal models (9) and in
humans (10) to be associated with impaired EDRF-mediated
vascular relaxation. Furthermore, ETS has also been shown
(11,12) to promote atherogenesis in the HC rabbit model.
Sex hormones alter vascular behavior and may mediate
gender differences in cardiovascular disease. Estrogens have
been shown to be acute vasodilators of the peripheral (13,14),
cerebral (15,16) and coronary vasculature (17–25). In vitro
studies demonstrate that physiologic levels of estrogens acutely
increase release of EDRFs, in particular nitric oxide (NO).
Basal release of nitric oxide from aortic rings is greater in
female than in male rabbits (26). In vivo studies of atheroscle-
rotic coronary arteries in primates (20–22) and humans (23)
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have demonstrated that estrogens acutely augment vasorelax-
ation induced by agents such as acetylcholine and serotonin,
which induce EDRF release. Studies of guinea pigs (27)
suggest that both endothelial and neuronal NO synthase are
subject to regulation by estrogen (27). Preliminary studies (28)
in perimenopausal women have suggested that estrogen sup-
plementation increases basal NO release in the peripheral
vasculature.
Active (29–31) and passive (32) tobacco smoking may be a
greater risk factor for cardiac disease in men than women.
However, the impact of gender on the effects of passive
exposure to ETS is unclear. Furthermore, the interaction
between physiologic concentrations of sex hormones and
pathophysiologic vascular states such as HC is not well defined.
We hypothesized that impairment of EDRF release by HC and
ETS would be differentially modulated by male and female sex
hormones. Therefore, in the present study we sought to
establish the effects of different sex hormones on endothelium-
mediated relaxation in normal, HC and ETS-exposed/HC
rabbits.
Methods
Protocol. The protocol was approved by the Institutional
Committee on Animal Research. Three groups of male New
Zealand White rabbits were studied: normal rabbits (n 5 8),
HC rabbits (n 5 7) and HC rabbits exposed to ETS (n 5 8).
HC and ETS-exposed/HC rabbits were rendered HC by a
high cholesterol diet over 13 consecutive weeks. The choles-
terol diet (Ziegler Bros., Inc.) consisted of 3% soybean oil and
0.3% cholesterol by weight. After 3 weeks of the high choles-
terol diet, induction of HC was confirmed by serum testing. At
3 weeks, rabbits were randomized to continue receiving the
high cholesterol diet (13 weeks) alone or a high cholesterol
diet (13 weeks) plus ETS exposure (weeks 3 to 13). Blood
samples were taken through ear venipuncture for serum
cholesterol at the start of the study and at 3, 9 and 13 weeks
(the last measure at euthanasia).
Rabbits were housed in individual cages, and those random-
ized to the ETS-exposed/HC group were placed in ETS
exposure chambers (model H 5500, BioClean, Lab Products
Inc.), 1.92 m 3 1.92 m 3 0.97 m (3.58 m3) that accommodated
eight rabbits. Rabbits were exposed to sidestream smoke from
Marlboro filter cigarettes (4 cigarettes/15 min for 6 h/day, 5
days/week) using a smoking machine (Heinr, Borgwald GMBH
RM 1/G, Hamburg, Germany) for 10 weeks from weeks 3 to
13. Three fans in the exposure chambers were adjusted to
ensure good air mixing within the smoking chamber. At the
end of the 6-h exposure period, the exhaust fan on the
BioClean unit was turned on and rapidly lowered the level of
ETS pollution in the exposure chamber to background levels
corresponding to those of the control animals until the next
day, when the BioClean unit was turned off and the smoking
machine was turned on again. Rabbits randomized to the HC
group were placed in separate cages in the same type of
exposure chamber in another room without a smoking ma-
chine.
Eight normal male New Zealand White rabbits, age
matched, fed a regular rabbit chow diet, served as normal
control animals.
Monitoring smoke exposure inside chambers. We moni-
tored the constituents of ETS (carbon monoxide, total partic-
ulate matter, respirable suspended particulates and air nico-
tine), as previously described (33).
Hematologic and biochemical analysis. Total serum cho-
lesterol, low density lipoprotein (LDL) cholesterol and triglyc-
eride levels were determined by automated enzymatic methods
(Coulter DART cholesterol reagent using the Dacos and
Dacos XL analyzers). The blood samples were drawn in the
morning (Tuesday to Friday) after 12 h of fasting and before
ETS exposure.
Harvesting of aortic rings. At week 21, rabbits were killed
by lethal injection with intravenous administration of pento-
barbital (130 mg/kg body weight) in accordance with our
institutional guidelines. The aorta was rapidly removed from
its origin (2 cm distal to the aortic valve) down to the
bifurcation of the internal iliac arteries. The segment immedi-
ately distal to the left subclavian artery was used in all animals
for measuring vascular reactivity. The aorta was dissected free
of connective tissue and fat. Arterial rings (2- to 3-mm
diameter) were cut into 5- to 7-mm lengths. One ring per
animal was studied. Each ring was suspended horizontally
between two stainless steel parallel wires for the measurement
of isometric tension, in individual organ baths containing
Krebs solution, composed of (mmol/liter): NaCl 118.3, KCl 4.7,
CaCl2 2.5, MgSO4 1.2, K2PO4 1.2 and glucose 11.1, bubbled
with 95% O2 and 5% CO2. Bath temperature was maintained
at constant 378C. Two side by side quadruple Radnotti organ
bath systems (Radnotti Glass Technologies Inc.) were used.
The isometric tension generated by the ring segment was
measured using Radnotti high sensitivity isometric transducers
(TRN001) and recorded continuously on an eight-channel
MacLab/8e recording system (Analog Digital Instruments,
Inc.) on MacLab Chart v3.3 (Analog Digital Instruments, Inc.)
recording software.
Vascular responsiveness to norepinephrine, acetylcholine
and nitroglycerin. Ring segments were stabilized at 4 g of rest
tension for 60 min before the study began. To measure
Abbreviations and Acronyms
ANOVA 5 analysis of variance
CAD 5 coronary artery disease
EC50 5 concentration at half-maximal response
EDRF 5 endothelium-derived relaxing factor
ED80 5 dose (concentration) to achieve 80% response
ETS 5 environmental tobacco smoke
GLM 5 general linear model
HC 5 hypercholesterolemia, hypercholesterolemic
LDL 5 low density lipoprotein
NO 5 nitric oxide
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responsiveness to norepinephrine and to calculate the dose
needed for precontraction, norepinephrine in increasing doses
(from 1029 to 1024 mol/liter) was added to each ring per bath.
For each ring, the dose of norepinephrine needed to achieve
80% maximal contraction (ED80) was calculated. The baths
were rinsed three times with fresh Krebs solution, and the rings
were allowed to stabilize for 1 h.
To determine endothelium-derived nitric oxide–mediated
vasorelaxation, aortic rings were exposed to acetylcholine.
Acetylcholine in increasing doses (from 1029 to 1024.5 mol/
liter) was added to the organ baths after the rings had been
precontracted by the ED80 dose of norepinephrine, and stable
tension had developed. At the end of the acetylcholine series,
the baths were rinsed twice with fresh Krebs solution, and the
rings were allowed to stabilize at baseline tension.
To determine endothelium-independent relaxation, nitro-
glycerin in increasing doses (from 1029 to 1025 mol/liter) was
added to the organ baths, after the rings had been precon-
tracted by the ED80 dose of norepinephrine, and stable
tension had developed. At the end of the nitroglycerin series,
the organ baths were rinsed twice with fresh Krebs solution,
and the rings were allowed to stabilize at baseline tension.
Effects of sex hormone incubation on acetylcholine-induced
relaxation. The effect of sex steroids on endothelium-
mediated relaxation was tested by incubation with physiologic
concentrations (1 nmol/liter) of either 17-beta-estradiol, tes-
tosterone or 17-beta-estradiol plus progesterone 30 min before
precontracting the ring with the EC80 dose of norepinephrine,
followed by the addition of acetylcholine (doses 1029 to 1024.5
mol/liter). Estradiol is known to acutely improve acetylcholine-
induced endothelium-dependent relaxation of the female ar-
terial vasculature within 20 to 30 min (21,23).
At the end of the organ bath experiment, the used ring
segment was preserved in 10% formalin solution for 24 h
before Sudan IV staining for determination of intimal lesion
area. The percentage of the surface involved by intimal lesions
was measured by planimetry and expressed as the percentage
of the overall area.
Drugs. Norepinephrine, acetylcholine, 17-beta-estradiol,
testosterone and progesterone were purchased from Sigma
Chemical Company. Nitroglycerin was purchased from Sol-
opak Laboratories Inc. Distilled water was used as the solvent
for norepinephrine, acetylcholine and nitroglycerin. Dimethl-
sulfoxide was used to initially dissolve 17-beta-estradiol, tes-
tosterone and progesterone. Distilled water was used to per-
form subsequent dilutions of the sex steroids.
Histologic Measurement. At the end of the organ bath
study, the ring was opened, pinned with the endothelial side
facing a cork board and placed in a normal saline bath. The
ring segment was fixed in 10% formalin and stained with the
lipophilic stain Sudan IV and photographed. The stained
lesions were estimated quantitatively by planimetry of the
sudanophilia in the photographs. The planimetric measure-
ments were made without knowledge of other data and were
calculated as the mean of two determinations.
Calculations and statistical analysis. Rabbits were killed
and aortic rings harvested in random order, and the ring/organ
bath experiments and data recording were performed by an
observer (S.J.H.) blinded to treatment group (normal, HC,
ETS-exposed/HC rabbits). Relaxation responses were ex-
pressed as percent change of net developed tension, concen-
tration at half-maximal response (EC50) and slope. Response
to norepinephrine was expressed as change in tension (g). A
curve of best fit was calculated for each ring, using the equation
for the Hill coefficient, and EC50 and slope were derived
(Kaleidagraph, version 3.0, Synergy Software).
One ring from the testosterone-incubated ETS-exposed/
HC group was not included in the analyses because its maximal
response to acetylcholine was .3 SD from the mean value for
that group.
The effects of HC and ETS on animal weights, intimal
lesions area and vascular reactivity were evaluated using a
general linear model (GLM) analysis of variance (ANOVA)
(Minitab Version 10.2, GLM procedure), including the pres-
ence or absence of cholesterol and ETS as main effects.
The effects of sex hormone incubation (no hormone, 17-
beta-estradiol alone, 17-beta-estradiol/progesterone combina-
tion, testosterone) on maximal acetylcholine-induced relax-
ation were evaluated using GLM ANOVA, including (the
presence or absence of) 17-beta-estradiol, progesterone and
testosterone as main effects, the ETS–sex hormone interaction
and the HC–sex hormone interaction. Testing the significance
of the interaction term specifically permitted us to test whether
the effects of ETS exposure were modified by the presence of
sex hormone incubation (beyond purely additive effects).
Because an ETS–testosterone effect on maximal relaxation
induced by acetylcholine was seen on the GLM ANOVA,
indicating that testosterone altered the effect of ETS on
relaxation, we tested for differences in the ETS-exposed/HC
group using one-way ANOVA with post hoc Student-Newman-
Keuls testing.
Because we previously published data on cholesterol values
in normal rabbits (33), we did not collect these data in the
present study. Therefore, only cholesterol values for HC and
ETS-exposed/HC rabbits were compared with a t test. A p
value ,0.05 was considered significant. Results are expressed
as mean value 6 SE.
Results
Animal data (Table 1). Body weight and food intake. Inges-
tion of a high cholesterol diet caused greater body weight (p 5
0.001), most likely because of the higher caloric value of the
cholesterol-rich diet. ETS did not affect body weight (p5 0.67)
but did reduce food intake (p 5 0.01).
Cholesterol levels. Total cholesterol levels of the ETS-
exposed/HC group were higher than those of the HC group
(1,359 6 203 vs. 820 6 133 mg/dl, p 5 0.04) but LDL
cholesterol (1116 27 vs. 896 19 mg/dl, respectively, p5 0.53)
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and triglyceride levels (89 6 11 vs. 66 6 7 mg/dl, respectively,
p 5 0.09) of both groups were similar.
ETS exposure. ETS exposure resulted in greater particulate
and carbon monoxide exposure.
Extent of intimal lesions. HC induced atherogenesis in the
aorta (p , 0.0005), and ETS induced further atherogenesis
(p 5 0.047) (Fig. 1).
Vascular reactivity (Table 2). Effect of smoking and HC on
vascular relaxation. HC impaired endothelium-dependent re-
laxation (p5 0.01) but did not affect endothelium-independent
relaxation (p 5 0.20). ETS further impaired endothelium-
dependent relaxation (p , 0.0005) but did not affect
endothelium-independent relaxation (p 5 0.66) (Fig. 1).
Effect of incubation physiologic concentrations of sex steroids
on vascular relaxation. Incubation with testosterone alone
reduced acetycholine-induced endothelium-dependent relax-
ation (p5 0.049), did not affect the HC-induced impairment of
endothelium-dependent relaxation (HC–testosterone interac-
tion: p 5 0.65) but accentuated the ETS-induced impairment
of endothelium-dependent relaxation (ETS–testosterone in-
teraction: p 5 0.03). Maximal relaxation in response to acetyl-
choline with testosterone incubation in the ETS-exposed/HC
group was significantly less (p , 0.05) than that in response to
acetycholine alone or acetylcholine with other hormone incu-
bation in the ETS-exposed/HC group.
Incubation with estrogen alone did not affect endothelium-
dependent relaxation (p 5 0.50) or ETS- or HC-induced
impairment of endothelium-dependent relaxation (HC–
Table 1. Body Weight, Food Ingestion, Serum Lipoprotein Levels and Extent of Intimal Lesions in the
Three Study Groups
Normal Group
(mean 6 SE)
HC Group
(mean 6 SE)
ETS-Exposed/HC Group
(mean 6 SE) p Value
Weight (kg) 3.566 0.05 4.04 6 0.10 3.99 6 0.11 0.001*
0.67†
Cholesterol (mg/dl) 7106 196 1,359 6 182 0.04
TGs (mg/dl) 666 7 89 6 11 0.53
LDL (mg/dl) 896 19 111 6 27 0.09
Food (g/day) 1.676 11 1.30 6 8 0.01
Air CO (ppm) 0.26 0.1 0.2 6 0.1 88.7 6 2.6 , 0.0005†
0.99*
Particles (mg/m3) 1.0 6 0.0 1.0 6 0.0 53.5 6 1.5 , 0.0005†
0.99*
Intimal lesions 0 35.76 12.6 49.1 6 7.6 , 0.0005*
(% surface area) 0.047†
*Normal versus hypercholesterolemic (HC) group. †Hypercholesterolemic versus environmental tobacco smoke
(ETS)–exposed/hypercholesterolemic group. LDL 5 low density lipoprotein cholesterol; TGs 5 triglycerides.
Figure 1. Effect of ETS and HC on intimal lesions and endothelium-
dependent and endothelium-independent relaxation. Left, Atheroscle-
rosis: effect of increasing the percent of surface covered by lipid.
Middle, Endothelium-dependent relaxation: effect of decreasing
acetylcholine-induced relaxation of aortic rings. Right, Endothelium-
independent relaxation: No change in nitroglycerin-induced relaxation
is seen.
803JACC Vol. 29, No. 4 HUTCHISON ET AL.
March 15, 1997:800–7 TESTOSTERONE WORSENS ENDOTHELIAL DYSFUNCTION
estradiol interaction: p 5 0.70; ETS–estradiol interaction: p 5
0.22). Incubation with estrogen plus progesterone did not
affect endothelium-dependent relaxation (p 5 0.89) or the
ETS- or HC-induced impairment of endothelium-dependent
relaxation (HC–estradiol plus progesterone interaction: p 5
0.81; ETS–estradiol plus progesterone interaction: p 5 0.43)
(Fig. 2, 3).
Discussion
The present study demonstrates that in an experimental
model of atherogenesis, 1) both HC and ETS induce athero-
genesis and endothelial dysfunction but do not alter
endothelium-independent relaxation. 2) Incubation with phys-
iologic levels of 17-beta-estradiol and 17-beta-estradiol/
progesterone does not influence endothelium-dependent re-
laxation nor does it alter the endothelial dysfunction induced
by HC or ETS exposure. 3) Incubation with physiologic levels
of testosterone reduces endothelium-dependent relaxation and
augments the endothelial dysfunction induced by ETS. Incu-
bation with physiologic levels of testosterone does not alter the
endothelial dysfunction induced by HC.
The goal of the present study was to examine the effect of
physiologic levels of sex hormones on vascular relaxation in an
animal model of HC and ETS exposure. We confirmed previ-
ously published studies (34–36) that demonstrated that HC
induces endothelial dysfunction and atherogenesis and studies
(11,12,37) that demonstrate that ETS exposure induces endo-
thelial dysfunction and atherogenesis.
In the present study, we examined the vascular effects of
physiologic effects of sex hormones. In male rabbits, estrogens
did not improve the impaired acetylcholine-mediated relax-
ation in the ETS-exposed/HC group. This finding may indicate
that the beneficial effect of estrogens does not extend beyond
the estrogen-deficient postmenopausal setting or that it is not
seen in men.
Testosterone has complex effects on vascular reactivity and
in some models has been associated with enhanced vasocon-
strictor action (38,39). Data on the effects of testosterone on
atherosclerosis and vascular reactivity are conflicting. In fe-
male postmenopausal lipid-fed cynomolgus monkeys, Adams
et al. (24) showed that testosterone supplementation was
associated with significantly greater atherosclerosis, although it
was also associated with improvement in vascular reactivity.
Shror et al. (38) demonstrated in guinea pigs in vitro that
testosterone can enhance coronary artery vascular reactivity to
thromboxane A2. Matsuda et al. (40) and Masuda et al. (41)
showed that testosterone increases thromboxane A2 receptor
density and responsiveness in rat aorta and platelets. In an
older study, Greenberg et al. (39) demonstrated increased
responses to norepinephrine and tyramine after testosterone
injection in the canine vasculature.
Studies in animal models of atherosclerosis have shown
that progesterone supplementation has variable effects on
acetylcholine-induced relaxation. Williams et al. (21) demon-
strated in postmenopausal lipid-fed female cynomolgus
monkeys that addition of cyclic or continuous medroxypro-
gesterone acetate to conjugated equine estrogen regimens
diminished endothelium-mediated dilation in response to ace-
tylcholine. Miller and Vanhoutte (42) showed that progester-
one itself had little effect on vasorelaxation but that it antag-
onized estrogen-induced vasorelaxation. Our study does not
support the observation that the addition of progesterone to
estradiol has a deleterious effect on endothelium-dependent
relaxation.
Clinical applications. Tobacco smoking (43) and HC
(44,45) are well established risk factors for coronary artery
disease (CAD). An association between increase in CAD
events and mortality and exposure to ETS has been reported
(32,46–55), suggesting that the coronary mortality rate in U.S.
never-smokers is increased 20% to 70% by passively breathing
Figure 2. HC rabbits with ETS exposure: dose–response curves of
acetylcholine-induced relaxation (net change [D] in developed tension)
alone (squares) and with 17-beta-estradiol (diamonds), testosterone
(triangles) or 17-beta-estradiol and progesterone incubation (circles).
Incubation with testosterone resulted in marked attenuation of
acetylcholine-induced vasorelaxation.
Table 2. Maximal Relaxation Responses to Acetylcholine in the
Presence of Various Sex Hormones
Normal Group
(n 5 8)
(mean 6 SE)
HC Group
(n 5 7)
(mean 6 SE)
ETS-Exposed/
HC Group
(n 5 8)
(mean 6 SE)
ACh 243 6 6.8 230 6 3.9 217 6 3.3*
ACh1E2 240 6 5.1 230 6 5.9 216 6 3.6*
ACh1E2/Prog 235 6 5.4 228 6 6.0 212 6 2.1*
ACh1Testo 238 6 5 232 6 6.1 23.5 6 1.6†
Nitroglycerin 275 6 8 270 6 7 274 6 8
ACh 5 acetylcholine; E2 5 17-beta-estradiol; E2/Prog 5 17-beta-estradiol
and progesterone; ETS 5 environmental tobacco smoke; HC 5 hypercholester-
olemia. pHC 5 0.006; pETS , 0.0005; pE2 5 0.50; pE2/Prog 5 0.89; pTesto 5 0.049.
*Less than †.
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tobacco smoke (56) and that passive ETS exposure constitutes
a risk for CAD.
Sex hormones may influence the incidence of atheroscle-
rotic vascular disease. There is a significant gender difference
in the incidence of CAD that is believed to be mediated in part
by sex hormones. It is generally thought that the presence of
estrogens imparts clinically important benefits on the course of
CAD (57).
However, it may be that testosterone in some situations
imparts a deleterious effect on vascular disease, such as in the
presence of smoking. The number of smoking-attributable
deaths in each state of the United States is twice as high for
male as for female smokers (29). The role of cigarette smoking
in thromboangiitis obliterans (Beurger’s disease), predomi-
nantly a disease of male smokers, is well established (58), and
more smoking-related deaths occur in male than in female
smokers (30). This gender-related difference in mortality may
be explained by the greater number of male smokers and the
fact that they smoke more cigarettes than do female smokers
(30). However, some data suggest that males smokers have a
greater increase in risk. In the American Cancer Society
25-state study (Current Population Study [CPS-1]), the esti-
mated relative risk of coronary heart disease mortality for
current male smokers .35 years old was 1.83 (95% confidence
interval [CI] 1.76 to 1.91) and for those 35 to 64 years old, 2.25
(95% CI 2.13 to 2.39) (30). The estimated relative risk for
female smokers was 1.40 (95% CI 1.29 to 1.51) and 1.81 (95%
CI 1.67 to 1.97), respectively. In the CPS-II trial, the estimated
relative risk of coronary heart disease mortality for current
male smokers .35 years old was 1.94 (95% CI 1.80 to 2.08),
and that for current female smokers was 1.78 (95% CI 1.62
to 1.97). Steenland et al. (32) recently published the CPS-II
data on passive smoking, which also suggest that men
exposed to ETS tended to have greater risk of vascular
events than women. Thus, male smokers may have greater
susceptibility to the complications of vascular disease (30),
and the results of the present study suggest that this
susceptibility may be mediated by a testosterone effect,
particularly by a testosterone–ETS interaction.
Limitations of the study. In the present study, only male
rabbits were studied. We do not know whether the interactions
between sex hormones, HC and ETS in aortic rings from
female rabbits would be different.
Acetylcholine induces relaxation by stimulation of endothe-
lial muscarinic receptors and subsequent release of nitric
oxide. However, endothelium-dependent vasorelaxation may
be mediated through other mechanisms, such as the aracha-
donic acid/prostacyclin pathway. We did not explore the con-
tribution of these other potential mechanisms to the impair-
ment of endothelial function by HC or ETS, or both, or their
potential modulation by sex hormones.
Conclusions. ETS exposure and HC cause atherogenesis
and endothelial dysfunction. Short-term exposure to physi-
ologic concentrations of testosterone worsens endothelial
dysfunction and prominently augments the endothelial dys-
function induced by ETS exposure. Further studies are
needed to elucidate the clinical interaction between ETS,
HC and sex hormones in populations predisposed to vascu-
lar disease.
Figure 3. Effect of hormone incubation on endothelium-dependent
relaxation of normal, HC and ETS-exposed/HC rabbit aorta. An HC
and ETS effect of reducing endothelium-dependent relaxation is seen.
Left, No effect of estradiol incubation on endothelium-dependent
relaxation is seen. Middle, No significant effect of estradiol/
progesterone (Prog) incubation on endothelium-dependent relaxation
is seen. Right, Testosterone (Testo) incubation of ETS-exposed/HC
rabbit aorta reduces relaxation but has no effect on HC and normal
rabbit aorta.
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